Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.
Biopharma companies must take into account a multitude of factors when considering physician prescribing behaviours, and need a more integrated “pull-through” strategy across their teams, from managed markets, to marketing, to field sales. Just as an engine needs a steady supply of fuel to run efficiently, prescriber-facing teams – the commercial engine of life sciences companies – need market access data and insights to accelerate brand success. Today, the challenge is optimizing this fuel supply, as market access and commercial teams often operate in a siloed way with regards to data, market changes and insights.
Join a vibrant conversation with industry leaders to discuss how the industry is changing and adapting to operationalise market access pull-through for improved commercial success. We will be discussing:
- Closing the gaps between market access and prescriber-facing teams
- The benefits of upskilling commercial teams with market access insights
- Solutions for integrating and operationalizing market access data across your organisation